Stay updated on Pembrolizumab in Hypermutation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hypermutation Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, reflecting a minor page update. No substantive study content or data appear to be changed.
    Difference
    0.0%
    Check dated 2026-08-08T19:58:32.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The revision label changed from v3.6.3 to v3.6.4, signaling a new version of the page content. This update is a version bump that reflects an updated page release.
    Difference
    0.0%
    Check dated 2026-07-25T12:57:32.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, signaling a small metadata update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-07-03T23:17:01.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.6.2 was added, replacing Revision: v3.6.0. This signals a minor version update to the site with no changes to the study details or substantive content.
    Difference
    0.0%
    Check dated 2026-06-27T01:49:18.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Recruitment status now shows no longer looking for participants, indicating enrollment is closed. The page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header alongside the new revision tag v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:25:18.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page introduces a new revision label (v3.5.5), replacing the previous v3.5.4, indicating a minor update to the page's template or metadata.
    Difference
    0.0%
    Check dated 2026-06-05T12:11:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hypermutation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.